View in EDS HTML Full Text PDF Full Text

Gout-Related Medication Use After Initiating Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Gout and Type 2 Diabetes: Population-Based Target Trial Emulation Studies.

Saved in:
Bibliographic Details
Title: Gout-Related Medication Use After Initiating Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Gout and Type 2 Diabetes: Population-Based Target Trial Emulation Studies.
Authors: McCormick N; Rheumatology and Allergy Clinical Epidemiology Research Center, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA.; The Mongan Institute, Department of Medicine, Massachusetts General Hospital, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Arthritis Research Canada, Vancouver, British Columbia, Canada., Burrack N; Clinical Research Center, Soroka University Medical Center, Beer-Sheva, Israel., Yokose C; Rheumatology and Allergy Clinical Epidemiology Research Center, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA.; The Mongan Institute, Department of Medicine, Massachusetts General Hospital, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA., Lu N; Arthritis Research Canada, Vancouver, British Columbia, Canada., Wexler DJ; Department of Medicine, Harvard Medical School, Boston, MA.; Diabetes Center, Massachusetts General Hospital, Boston, MA., Rai SK; Rheumatology and Allergy Clinical Epidemiology Research Center, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA.; The Mongan Institute, Department of Medicine, Massachusetts General Hospital, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA., Challener GJ; Rheumatology and Allergy Clinical Epidemiology Research Center, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA.; The Mongan Institute, Department of Medicine, Massachusetts General Hospital, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA., Aviña-Zubieta JA; Arthritis Research Canada, Vancouver, British Columbia, Canada.; Division of Rheumatology, Department of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada., McCoy RG; Division of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.; University of Maryland Institute for Health Computing, North Bethesda, MD., Abuhasira R; Clinical Research Center, Soroka University Medical Center, Beer-Sheva, Israel., Choi HK; Rheumatology and Allergy Clinical Epidemiology Research Center, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA.; The Mongan Institute, Department of Medicine, Massachusetts General Hospital, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Arthritis Research Canada, Vancouver, British Columbia, Canada.
Source: Diabetes care [Diabetes Care] 2026 Mar 01; Vol. 49 (3), pp. 460-470.
Publication Type: Journal Article
Journal Info: Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41615420
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Gout-Related Medication Use After Initiating Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Gout and Type 2 Diabetes: Population-Based Target Trial Emulation Studies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22McCormick+N%22">McCormick N</searchLink>; Rheumatology and Allergy Clinical Epidemiology Research Center, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA.; The Mongan Institute, Department of Medicine, Massachusetts General Hospital, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Arthritis Research Canada, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Burrack+N%22">Burrack N</searchLink>; Clinical Research Center, Soroka University Medical Center, Beer-Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Yokose+C%22">Yokose C</searchLink>; Rheumatology and Allergy Clinical Epidemiology Research Center, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA.; The Mongan Institute, Department of Medicine, Massachusetts General Hospital, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Lu+N%22">Lu N</searchLink>; Arthritis Research Canada, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Wexler+DJ%22">Wexler DJ</searchLink>; Department of Medicine, Harvard Medical School, Boston, MA.; Diabetes Center, Massachusetts General Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Rai+SK%22">Rai SK</searchLink>; Rheumatology and Allergy Clinical Epidemiology Research Center, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA.; The Mongan Institute, Department of Medicine, Massachusetts General Hospital, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Challener+GJ%22">Challener GJ</searchLink>; Rheumatology and Allergy Clinical Epidemiology Research Center, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA.; The Mongan Institute, Department of Medicine, Massachusetts General Hospital, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Aviña-Zubieta+JA%22">Aviña-Zubieta JA</searchLink>; Arthritis Research Canada, Vancouver, British Columbia, Canada.; Division of Rheumatology, Department of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22McCoy+RG%22">McCoy RG</searchLink>; Division of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.; University of Maryland Institute for Health Computing, North Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Abuhasira+R%22">Abuhasira R</searchLink>; Clinical Research Center, Soroka University Medical Center, Beer-Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Choi+HK%22">Choi HK</searchLink>; Rheumatology and Allergy Clinical Epidemiology Research Center, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA.; The Mongan Institute, Department of Medicine, Massachusetts General Hospital, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Arthritis Research Canada, Vancouver, British Columbia, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227805975%22">Diabetes care</searchLink> [Diabetes Care] 2026 Mar 01; Vol. 49 (3), pp. 460-470.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Diabetes+Association%22">American Diabetes Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7805975 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1935-5548 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201495992%22">01495992 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes Care <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41615420
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2337/dc25-1713
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 460
    Titles:
      – TitleFull: Gout-Related Medication Use After Initiating Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Gout and Type 2 Diabetes: Population-Based Target Trial Emulation Studies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: McCormick N
      – PersonEntity:
          Name:
            NameFull: Burrack N
      – PersonEntity:
          Name:
            NameFull: Yokose C
      – PersonEntity:
          Name:
            NameFull: Lu N
      – PersonEntity:
          Name:
            NameFull: Wexler DJ
      – PersonEntity:
          Name:
            NameFull: Rai SK
      – PersonEntity:
          Name:
            NameFull: Challener GJ
      – PersonEntity:
          Name:
            NameFull: Aviña-Zubieta JA
      – PersonEntity:
          Name:
            NameFull: McCoy RG
      – PersonEntity:
          Name:
            NameFull: Abuhasira R
      – PersonEntity:
          Name:
            NameFull: Choi HK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2026 Mar 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1935-5548
          Numbering:
            – Type: volume
              Value: 49
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Diabetes care
              Type: main
ResultId 1